-
- Homepage
-
- Efficacy
-
- Dosing
-
- About
-
- NCCN Recommendation
-
- Request a Call Back
-
- Homepage (Mobile)
-
- Mobile ISI
Onivyde Post-Launch HCP Website
Brand: Onivyde (irinotecan liposome), Injection
Parent Company: Ipsen
Drug Type: Boxed Warning
Drug Category: Oncology
Campaign: Post-Launch
Targeting: HCPs
Patient Website:
HCP Website: https://www.onivyde.com/